Ramos, Qiarra Jane .

HRN: 23-43-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2025
AMPICILLIN 500MG (VIAL)
03/07/2025
03/14/2025
IV
400 Mg
Q6h
Pcap C
Waiting Final Action 
03/09/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/09/2025
03/15/2025
IV
120mg
Q24hours
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: